| 000 | 00817cam a2200157 4500500 | ||
|---|---|---|---|
| 005 | 20250112040057.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_aYsebaert, Loïc _eauthor |
| 245 | 0 | 0 | _aMain clinical studies of Bruton’s tyrosine kinase inhibitors (BTKis) |
| 260 | _c2024. | ||
| 500 | _a86 | ||
| 520 | _aQuality of life evaluation is crucial in therapeutic trials in hematology, but is not yet recognized as the only true patient-centered primary endpoint. For chronic lymphocytic leukemia patients, how can we move beyond focusing solely on progression-free survival to truly consider overall survival with good quality of life? | ||
| 786 | 0 | _nHématologie | 30 | Special Issue 1 | 2024-06-02 | p. 44-46 | 1264-7527 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/journal-hematologie-2024-Supp1-page-44?lang=en |
| 999 |
_c175133 _d175133 |
||